Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Preparation of Transfer Report and Summary – V 2.0

Posted on By

Analytical Method Development: SOP for Preparation of Transfer Report and Summary – V 2.0

Standard Operating Procedure for Preparation of Transfer Report and Summary in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/304/2025
Supersedes SOP/AMD/304/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to define the process for preparing a comprehensive Transfer Report and Summary following the successful completion of analytical method transfer exercises.

This includes data compilation, result evaluation, interpretation of acceptance criteria, deviation handling, and documentation to ensure regulatory compliance and traceability.

2. Scope

This SOP is applicable to all analytical method transfers—qualitative and quantitative—conducted between the Sending Unit (SU) and Receiving Unit (RU) within the organization or with external contract laboratories.

3. Responsibilities

  • RU Analyst: Submits all raw data, observations, and completed worksheets to AMD representative.
  • SU Scientist: Assists in data interpretation and comparative analysis between SU and RU performance.
  • QA Reviewer: Reviews report content, verifies completeness, and ensures compliance with method transfer protocol.
  • AMD Documentation Officer: Compiles the transfer report in standardized format and files it with supporting annexures.
See also  Analytical Method Development: SOP for Documentation of Analytical Calculations and Worksheets - V 2.0

4. Accountability

The AMD Section Head is accountable for ensuring the preparation, review, approval, and archival of all analytical method transfer reports and associated summaries as per GMP requirements and ICH guidelines.

5. Procedure

5.1 Collection and Verification of Data

  1. Collect raw data from RU including instrument printouts, chromatograms, method execution worksheets, and calibration records.
  2. Cross-check against SU method parameters for alignment with transfer protocol.
  3. Ensure inclusion of data from system suitability, precision, accuracy, linearity, robustness, and ruggedness evaluations.

5.2 Data Compilation and Tabulation

  1. Use Annexure-1 format to compile test parameters, results from SU and RU, and acceptance criteria.
  2. Document variations and highlight critical deviations observed during execution.
  3. Summarize key statistical metrics (e.g., RSD, % Recovery, correlation coefficients) for each validation attribute.

5.3 Transfer Summary Drafting

  1. Write a summary of the transfer exercise, including:
    • Purpose and scope of transfer
    • Test parameters and methodology
    • Comparison of SU and RU results
    • Outcome of acceptance criteria evaluation
    • Summary of deviations and resolutions
  2. Attach graphical representation where applicable (e.g., overlaid chromatograms, linearity curves).
See also  Analytical Method Development: Conductivity Method Development - V 2.0

5.4 Deviation Management and CAPA

  1. For any deviations noted, record in Deviation Log (Annexure-2).
  2. Perform Root Cause Analysis (RCA) using Ishikawa diagram or 5-Whys analysis.
  3. Document CAPA plan, timelines, and responsible personnel in the report summary.

5.5 Approval and Archival

  1. Submit completed Transfer Report and Summary to QA for review and approval.
  2. Ensure all supporting documentation including instrument logs, audit trails, and batch records are included.
  3. Assign report ID and archive the approved version in the central AMD documentation repository.

6. Abbreviations

  • RU: Receiving Unit
  • SU: Sending Unit
  • RSD: Relative Standard Deviation
  • CAPA: Corrective and Preventive Action
  • RCA: Root Cause Analysis

7. Documents

  1. Method Transfer Report Template – Annexure-1
  2. Deviation Log Format – Annexure-2
  3. CAPA Summary Sheet – Annexure-3

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • ICH Q9 – Quality Risk Management
  • WHO Technical Report Series 996, Annex 7
  • 21 CFR Part 211 – Good Manufacturing Practice for Finished Pharmaceuticals
See also  Analytical Method Development: SOP for System Suitability Evaluation - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Sachin Kumar Priya Nair Dr. Harshita Goyal
Designation AMD Analyst QA Reviewer Head – Analytical Method Development
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Method Transfer Report Template

This includes: protocol ID, RU and SU names, method description, acceptance criteria, detailed comparative result table, summary of observations, and conclusions.

Annexure-2: Deviation Log Format

Deviation ID Description Root Cause Corrective Action Status
DEV-304-01 High RSD in robustness test Improper sample dilution Training and dilution SOP revision Closed

Annexure-3: CAPA Summary Sheet

Details CAPA issued for deviation: assigned actions, deadlines, responsible analysts, and effectiveness check strategy.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Enhanced structure and clarified statistical reporting guidance Annual SOP review Dr. Harshita Goyal
15/07/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Using Impact Assessment Tools During SOP Updates
Next Post: Elixir Department: SOP for Preservative Effectiveness Testing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version